Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer

Oluwadamilola M. Fayanju, Carolyn S. Hall, Jessica Bowman Bauldry, Mandar Karhade, Lily M. Valad, Henry M. Kuerer, Sarah M. DeSnyder, Carlos H. Barcenas, Anthony Lucci

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Background Obesity (BMI≥30) may be an etiologic and prognostic factor in inflammatory breast cancer (IBC). We examined the relationship between BMI, pathologic complete response (pCR), and circulating-tumor-cell (CTC) levels in IBC. Methods Cohort included IBC patients diagnosed 2005–2015 who had neoadjuvant chemotherapy during a prospective trial on CTCs and pathologic review describing pCR. Chi-square, logistic regression, and Cox proportional hazards models were used to identify clinicopathologic associations with event-free survival (EFS). Results Of 73 patients, 61 (84%) had CTC values, 22 (30%) achieved a pCR, and 39 (53%) were obese. There was no difference between obese and non-obese patients for pCR rates (31% vs. 29%, p = 0.90) or presence of CTCs (23% vs. 26%, p = 0.80). Among non-obese patients, CTCs were associated with worse EFS (HR 11.69, p < 0.01), but among obese patients, there was no difference in EFS between those with and without CTCs. Conclusions BMI mediates CTCs' prognostic significance in IBC.

Original languageEnglish (US)
Pages (from-to)666-671
Number of pages6
JournalAmerican Journal of Surgery
Volume214
Issue number4
DOIs
StatePublished - Oct 2017

Keywords

  • Body mass index
  • Circulating tumor cells
  • Inflammatory breast cancer
  • Obesity
  • Pathologic complete response
  • Prognosis

ASJC Scopus subject areas

  • Surgery

Fingerprint

Dive into the research topics of 'Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer'. Together they form a unique fingerprint.

Cite this